Literature DB >> 7474921

The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells.

M Derenzini1, V Sirri, D Trerè, R L Ochs.   

Abstract

BACKGROUND: The quantity of the silver-stained nucleolar proteins (AgNOR proteins) measured in situ in cytohistologic preparations is related to the rapidity of cell proliferation. The term "AgNOR proteins" comprises several proteins. The relationship between the individual AgNOR protein amount and cell proliferating activity is not yet known. We studied the quantitative distribution of the individual AgNOR proteins, with specific attention to the two major AgNOR proteins, nucleolin and protein B23, in seven human cancer cell lines characterized by different cell doubling times.
DESIGN: The doubling time of cancer cells was measured by counting the asynchronously growing cells at regular time intervals. The AgNOR proteins were quantified in situ, after a specific one-step staining procedure, by computerized image analysis. For the quantitative evaluation of nucleolin and protein B23, two methods were followed. Nuclear proteins after separation by SDS-PAGE were transferred onto nitrocellulose membranes and were either: 1) stained by the silver staining procedure for AgNOR proteins or 2) treated with anti-nucleolin and anti-protein B23 mAb followed by reaction with secondary Ab linked to peroxidase and revealed by chemiluminescence and autoradiography. In both cases, measurement of individual AgNOR protein and nucleolin and protein B23 amount was carried out using computerized densitometric analysis.
RESULTS: Integrated density values of the silver-stained bands at 105 kDa (nucleolin) and 38 to 39 kDa (protein B23) represented, in all cell lines, more than 60% of the total silver-stained band value. A relationship was found between the densitometric values of silver-stained nucleolin and protein B23 and rapidity of cell proliferation (r = 0.85 and r = 0.86, respectively, p < 0.05). The values of nucleolin and protein B23 obtained using the Western blots were strictly related to the rapidity of cell proliferation (r = 0.93 and 0.96, respectively, p < 0.001). Finally, a good correlation was observed between the mean AgNOR protein area value, as defined in cytologic preparations in situ, and nucleolin and protein B23 amounts as evaluated in silver-stained nitrocellulose membranes (r = 0.92 and r = 0.90, respectively, p < 0.01) and in Western blots (r = 0.95 and r = 0.94, respectively, p < 0.001).
CONCLUSIONS: These data indicate that the quantitative changes of AgNOR proteins observed in cytohistologic preparations in situ mainly reflect the quantitative changes of nucleolin and protein B23 and demonstrate that nucleolin and protein B23 amounts are inversely related to cell doubling time in human cancer cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7474921

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  41 in total

1.  UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions.

Authors:  H Ge
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

Review 2.  The regulation of AβPP expression by RNA-binding proteins.

Authors:  Cara J Westmark; James S Malter
Journal:  Ageing Res Rev       Date:  2012-04-05       Impact factor: 10.895

3.  Nucleolin Binds to the Proliferating Cell Nuclear Antigen and Inhibits Nucleotide Excision Repair.

Authors:  Chonglin Yang; Myoung Sook Kim; Devulapalli Chakravarty; Fred E Indig; France Carrier
Journal:  Mol Cell Pharmacol       Date:  2009

4.  The Nucleolus Takes Control of Protein Trafficking Under Cellular Stress.

Authors:  Narasimharao Nalabothula; Fred E Indig; France Carrier
Journal:  Mol Cell Pharmacol       Date:  2010

5.  Over Expression of Nucleophosmin and Nucleolin Contributes to the Suboptimal Activation of a G2/M Checkpoint in Ataxia Telangiectasia Fibroblasts.

Authors:  Narasimharao Nalabothula; Devulapalli Chakravarty; Adam Pierce; France Carrier
Journal:  Mol Cell Pharmacol       Date:  2010

6.  Nucleolin maintains embryonic stem cell self-renewal by suppression of p53 protein-dependent pathway.

Authors:  Acong Yang; Guilai Shi; Chenlin Zhou; Rui Lu; Hui Li; Lei Sun; Ying Jin
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

7.  Human anti-nucleolin recombinant immunoagent for cancer therapy.

Authors:  Dario Palmieri; Timothy Richmond; Claudia Piovan; Tyler Sheetz; Nicola Zanesi; Fulvia Troise; Cindy James; Dorothee Wernicke; Fata Nyei; Timothy J Gordon; Jessica Consiglio; Francesco Salvatore; Vincenzo Coppola; Flavia Pichiorri; Claudia De Lorenzo; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

8.  Nucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patient.

Authors:  Rolf K Swoboda; Rajasekharan Somasundaram; Laura Caputo; Klara Berencsi; Paul von Franzke; Douglas D Taylor; Francesco M Marincola; Neal J Meropol; Elin Sigurdson; Eric Miller; Dorothee Herlyn
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

9.  Thrombopoietin upregulates nucleolin mRNA and protein in thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.

Authors:  Takatoshi Ito; Mitsuhiro Fujihara; Atsushi Oda; Shinobu Wakamoto; Miki Yamaguchi; Norio Komatsu; Hiroshi Miyazaki; Hiroshi Azuma; Hisami Ikeda; Kenji Ikebuchi
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

10.  Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.

Authors:  John S Vorhies; John J Nemunaitis
Journal:  Biologics       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.